To further verify effects of ET-1 on the development of TMEV-induced demyelinating disease, we examined virus-induced demyelination upon administration of SJL mice with ET-1 receptor inhibitors (BQ610 or BQ788) during viral infection. Here, EDN1 is linked to demyelinating disease.